FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 666 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma Mortality Trends for Most Cancers Remain Favourable In the EU, Although the Absolute Number of Cancer Deaths Is Not Declining Due To Population Ageing MOST POPULAR Genetic Signature May Help Tailor Treatment for Meningioma December 21, 2023 Health of Gut Microbes May Affect Survival after Stem Cell Transplant March 25, 2020 Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing... April 10, 2020 What could DeepMind ‘solving’ the protein folding problem mean for cancer... December 23, 2020 Load more HOT NEWS Neoadjuvant Histotype-Tailored Treatment with Trabectedin Not Inferior to Standard Chemotherapy with... Pyrotinib in HER2-mutated Advanced NSCLC Previously Treated with Chemotherapy EMA Recommends Extension of Therapeutic Indications for Lisocabtagene Maraleucel Cross-Border Network of European Specialists Provides New Treatment Options For Women...
